Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Photodynamic therapy combined with immunotherapy: Nov 15/23

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Nov 16, 2023 9:51am

214 Views

Post# 35738882

RE:Photodynamic therapy combined with immunotherapy: Nov 15/23

This to me, is the Holy Grail for Ruvidar. Long research paper but glanced through it.. Even standalone, the results have been great but when combined with an immunotherapy, should get amazing results.. The perception of lingering side effects needs to be overcome. Even vaccines are mentioned in this paper. But first, let's hope they get enough money to survive. Thanks for sharing.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle